Atlas Trials

Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

Clinical trial NCT00565487 · COMPLETED

Trial details

NCT number
NCT00565487
Sponsor
Milton S. Hershey Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2007-12-01
Primary completion
2014-08-05
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.